Company: CERO
Filing Date: 2025-12-05
Form Type: S-1
Source: 0001213900-25-118817
Chunk: 441

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-12-05
Form: S-1
Chunk 441
---
 for the period from February 14, 2024 through December 31, 2024 was $ 44,077and Predecessor contributions during the period from January 1, 2024 through February 13, 2024 was $ 8,657. The Predecessor made contributions of $ 63,344during the year ended December 31, 2023. F-64

NOTE 14 – RELATED-PARTY TRANSACTIONS

In February 2024, we issued
and sold an aggregate of shares of Series A Preferred Stock, Series A Common Warrants and Preferred Warrants, at a price
of $ per share of Series A Preferred Stock, for aggregate cash proceeds of approximately $ million, plus additional cash proceeds
of up to $ million if the Preferred Warrants are exercised.

The following table summarizes
the shares of our Series A Preferred Stock issued to our related parties:

| Purchasers                              |     | Shares             
 of                 
 Series A Preferred 
 Stock              |       |     | Total    
 Purchase 
 Price    |           |
|:----------------------------------------|:----|:-------------------|------:|:----|:---------|----------:|
| Daniel Corey(1)                         |     |                    |   150 |     | $        |   150,000 |
| Atwood-Edminster Trust dtd 4-2-2000 (2) |     |                    | 1,002 |     | $        | 1,002,000 |
| Chris Ehrlich(3)                        |     |                    |   275 |     | $        |   275,000 |

| (1) | Daniel Corey served as the Chief Technology Officer and a member of the board of directors of the Company from February 2024 to September 2024, and previously served as Chief Executive Officer, Chief Scientific Officer, and a member of the board of directors of Legacy CERo until the closing of the Business Combination in February 2024. |

| (2) | Brian G. Atwood served as Chairman and Chief Executive Officer of the Company from February 2024 to September 2024, and previously served as Chairman of PBAX until the closing of the Business Combination in February 2024. Mr. Atwood is currently a member of the board of directors of the Company and serves as a trustee of Atwood-Edminster Trust dtd 4-2-2000. |

| (3) | Chris Ehr